Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Bladder Cancer treatment details. Chemotherapy. Akita University School of Medicine, Akita, Japan



Survival: 13.1 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs:
Country: Japan
   
City/State/Province: Akita
   
Hospital: Akita University School of Medicine
   
Journal: Link
   
Date: 10/2011

Description:
Patients:
This phase 2 study involved 35 advanced urothelial carcinoma patients. The median patient age was 68 years and 82.9% were male.

Treatment:
Patients were treated with the chemotherapy agents gemcitabine, carboplatin, and docetaxel.

Toxicities:
The most severe toxicities were of grade 4 and included neutropenia, anemia, and diarrhea. Grade 3 anorexia and thrombocytopenia were also reported.

Results:
The median overall survival was 13.1 months.

Correspondence: Dr. Hiroshi Tsuruta; email: tsurutah@doc.med.akita-u.ac.jp

E-mail to a Friend Email Physician More Information